These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19099297)
1. Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice. Li X; Hoffman AF; Peng XQ; Lupica CR; Gardner EL; Xi ZX Psychopharmacology (Berl); 2009 May; 204(1):1-11. PubMed ID: 19099297 [TBL] [Abstract][Full Text] [Related]
2. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice. Mereu M; Tronci V; Chun LE; Thomas AM; Green JL; Katz JL; Tanda G Addict Biol; 2015 Jan; 20(1):91-103. PubMed ID: 23910902 [TBL] [Abstract][Full Text] [Related]
3. Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors. Ramiro-Fuentes S; Fernandez-Espejo E Psychopharmacology (Berl); 2011 Apr; 214(4):949-59. PubMed ID: 21128069 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. Xi ZX; Gilbert JG; Peng XQ; Pak AC; Li X; Gardner EL J Neurosci; 2006 Aug; 26(33):8531-6. PubMed ID: 16914679 [TBL] [Abstract][Full Text] [Related]
5. mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism. Li X; Peng XQ; Jordan CJ; Li J; Bi GH; He Y; Yang HJ; Zhang HY; Gardner EL; Xi ZX Sci Rep; 2018 Feb; 8(1):3686. PubMed ID: 29487381 [TBL] [Abstract][Full Text] [Related]
6. Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors. Ramiro-Fuentes S; Ortiz O; Moratalla R; Fernandez-Espejo E Neuroscience; 2010 May; 167(2):205-15. PubMed ID: 20167255 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats. Delis F; Polissidis A; Poulia N; Justinova Z; Nomikos GG; Goldberg SR; Antoniou K Int J Neuropsychopharmacol; 2017 Mar; 20(3):269-278. PubMed ID: 27994006 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. Chefer VI; Shippenberg TS Eur J Neurosci; 2006 Jan; 23(1):229-38. PubMed ID: 16420432 [TBL] [Abstract][Full Text] [Related]
11. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior. Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354 [TBL] [Abstract][Full Text] [Related]
12. Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice. Xi ZX; Peng XQ; Li X; Song R; Zhang HY; Liu QR; Yang HJ; Bi GH; Li J; Gardner EL Nat Neurosci; 2011 Jul; 14(9):1160-6. PubMed ID: 21785434 [TBL] [Abstract][Full Text] [Related]
13. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. Cathala A; Devroye C; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U Addict Biol; 2015 May; 20(3):445-57. PubMed ID: 24661380 [TBL] [Abstract][Full Text] [Related]
14. Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor. Shippenberg TS; Hen R; He M J Neurochem; 2000 Jul; 75(1):258-65. PubMed ID: 10854269 [TBL] [Abstract][Full Text] [Related]
15. Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice. Ward SJ; Walker EA Behav Pharmacol; 2009 Oct; 20(7):605-13. PubMed ID: 19745722 [TBL] [Abstract][Full Text] [Related]
16. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant. Gerdeman GL; Schechter JB; French ED Neuropsychopharmacology; 2008 Oct; 33(11):2747-59. PubMed ID: 18059436 [TBL] [Abstract][Full Text] [Related]
17. Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism. Loewinger GC; Beckert MV; Tejeda HA; Cheer JF Neuropharmacology; 2012 Jun; 62(7):2192-201. PubMed ID: 22306525 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. Thanos PK; Gopez V; Delis F; Michaelides M; Grandy DK; Wang GJ; Kunos G; Volkow ND Alcohol Clin Exp Res; 2011 Jan; 35(1):19-27. PubMed ID: 20958329 [TBL] [Abstract][Full Text] [Related]
19. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135. De Luca MA; Castelli MP; Loi B; Porcu A; Martorelli M; Miliano C; Kellett K; Davidson C; Stair JL; Schifano F; Di Chiara G Neuropharmacology; 2016 Jun; 105():630-638. PubMed ID: 26686391 [TBL] [Abstract][Full Text] [Related]